Abbott Laboratories (ABT)

125.83
NYSE
Prev Close 124.71
Day Low/High 124.86 / 127.09
52 Wk Low/High 105.36 / 142.60
Exchange NYSE
Shares Outstanding 1768.29B
Market Cap 220.52B
P/E Ratio 60.02
Div & Yield N.A. (N.A)

Latest News

This Medical Device Maker Should Pick Up the Pace in 2022

This Medical Device Maker Should Pick Up the Pace in 2022

Here's why down-and-out Medtronic could see a good year ahead.

These Health Care Dividend Stocks Can Help Build Recession Immunity

These Health Care Dividend Stocks Can Help Build Recession Immunity

Here's why investors should take a closer look at AbbVie, Cardinal Health and Walgreens Boots Alliance -- and their solid dividends.

Abbott Upgraded at Atlantic Equities

Abbott Labs Earnings Are Astounding! Here's My Trade Idea

Abbott Labs Earnings Are Astounding! Here's My Trade Idea

ABT reported its third quarter financial performance on Wednesday morning.

Algorithmic Control, Bearish Kass, Budget Framework, Trading Netflix, Microsoft

Algorithmic Control, Bearish Kass, Budget Framework, Trading Netflix, Microsoft

Plus, the Chinese government raised $4 billion in dollar bonds on Tuesday, borrowing on the cheap from the international community.

Can Abbott Labs Get Its Act Together?

Can Abbott Labs Get Its Act Together?

Traders finally seem to be rejecting the downside of ABT.

D.C.'s Not Done Deals, Dissonant Volume, Price Pressures, Real Real Estate Pain

D.C.'s Not Done Deals, Dissonant Volume, Price Pressures, Real Real Estate Pain

Plus, a closer look at a tough Thursday for equities and a rundown on the stocks the author is accumulating.

Jim Cramer: The Days of Amazon as Death Star Are Over

Jim Cramer: The Days of Amazon as Death Star Are Over

Brick and Mortar strikes back.

Weights on the Market, Fed Factions, Charting the S&P & Nasdaq, Nvidia the Beast

Weights on the Market, Fed Factions, Charting the S&P & Nasdaq, Nvidia the Beast

The U.S. economy's next recession has already been scheduled. We just don't have a specific quarter just yet.

Jim Cramer: The Fortunes Have Been Restored for Regeneron and Abbott

Jim Cramer: The Fortunes Have Been Restored for Regeneron and Abbott

The tables have turned, their stocks have been up, and I think they go higher still.

Abbott Labs Is Poised to Break Out to New Highs

Abbott Labs Is Poised to Break Out to New Highs

Let's check out the charts of ABT.

Jim Cramer: To Every Market Sector, Turn, Turn, Turn

Jim Cramer: To Every Market Sector, Turn, Turn, Turn

To the melody of the Byrds' famed song, I want you to know: There's a time to buy the industrials, a time to sell the banks; a time to bid for health cares, a time to dump the techs. ...

Green Tuesday, Delta Economy, Policing Cryptos, Lockheed vs General Dynamics

Green Tuesday, Delta Economy, Policing Cryptos, Lockheed vs General Dynamics

The Delta virus has more power to control both fiscal and monetary policy than does the data or do any of our leaders individually.

3 High-Yield Dividend Aristocrats to Buy

3 High-Yield Dividend Aristocrats to Buy

These names have demonstrated over a long period they have the business models and growth prospects to raise their dividend payments each year.

Crypto Pep Rally, S&P Wonder Line, Minerd Unmuted, Chip Keepers, Trading Moderna

Crypto Pep Rally, S&P Wonder Line, Minerd Unmuted, Chip Keepers, Trading Moderna

Small-caps and mid-caps are still picking first downs on every play, storming back from a badly oversold condition that has just about normalized.

A 5-Stock Healthcare Portfolio With a 5.5% Yield

A 5-Stock Healthcare Portfolio With a 5.5% Yield

These names offer appeal to both growth and dividend investors.

'All or None' Marketplace, Ransomware Beef, Trading AMC and Abbott Labs

'All or None' Marketplace, Ransomware Beef, Trading AMC and Abbott Labs

Also, the ISM survey results showed us a few trends that at least appear as potential if not troubling question marks on the horizon.

A Mild and Mixed Market Favors Speculative Small-Caps

A Mild and Mixed Market Favors Speculative Small-Caps

Probably the best news right now is that individual stock picking has improved.

Abbott Rated New Overweight at Barclays

Best Stocks With DRIP Plans Right Now

Best Stocks With DRIP Plans Right Now

These Dividend Aristocrats have free DRIPs, long histories of raising their dividends, and attractive yields well above the market average.

Key Chart Favors a Nice Rise in Abbott Labs Later This Year

Key Chart Favors a Nice Rise in Abbott Labs Later This Year

The technical signals indicate the odds of further weakness in the health care company's shares are low.

Investors on United Airlines Could See a Bumpy Ride Ahead

Investors on United Airlines Could See a Bumpy Ride Ahead

Consider other 'travel plans.'

New Moon on Monday, Fair Warning on Semis and Small-Caps, Ballad of Nvidia, IBM

New Moon on Monday, Fair Warning on Semis and Small-Caps, Ballad of Nvidia, IBM

Always, always, always stick to your rules. Always. This is why we have targets, pivots and panics.

We've Changed Our Strategy on Abbott Laboratories

We've Changed Our Strategy on Abbott Laboratories

The charts are more mixed now.

Revisiting an S&P 500 Chart Setup and Tracking 2 Stocks on Pullbacks

Revisiting an S&P 500 Chart Setup and Tracking 2 Stocks on Pullbacks

Microsoft and Abbott Laboratories are the names that are worth watching.

Jim Cramer: There's Good Risk and Bad Risk

Jim Cramer: There's Good Risk and Bad Risk

Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.

Here's a Quick Technical Update on Abbott Laboratories

Here's a Quick Technical Update on Abbott Laboratories

Traders should continue to hold existing longs on ABT.

Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts

Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts

Wednesday afternoon the Fed's Federal Open Market Committee will publish the central bank's first official policy statement of 2021.